Cardiovascular Drugs Market – SGLT2 Inhibitors Expanding...

adicionou um novo artigo Health

2026-09-22 07:35:27 -

Cardiovascular Drugs Market – SGLT2 Inhibitors Expanding Beyond Diabetes into Heart Failure

Market OverviewSGLT2 inhibitors are expanding beyond diabetes into heart failure and chronic kidney disease, reshaping the cardiovascular drugs market through a powerful cardiorenal treatment paradigm. These therapies reduce hospitalization for heart failure and slow kidney disease progression, leading guidelines to adopt them as foundational therapy across multiple indications. The...

0 Comentários 0 Compartilhamentos 201 Visualizações 0 Anterior